Cell Impact : reports third quarter results for 2020

Cell Impact reports

third quarter results for 2020

Cell Impact AB	PRESS RELEASE	2020-11-05
www.cellimpact.com
IR contact	Cell Impact AB (Nasdaq First North GM: CI B) reports the following financial
Pär Teike, CEO	summary for the third quarter.
[e-mail]
[phone]	» Revenues for the quarter were SEK 8.5 million (3.5).
	» Operating result was SEK -5.7 million during the quarter (-9.0).
	» The Group's result after financial items was SEK -6.1 million (-9.0) during the quarter.
	» Earnings per share, attributable to the shareholders of the Parent Company, totaled
	SEK -0.12(-0.20) during the quarter.

» Equity was SEK 52.3 million (62.2) or SEK 1.01 per share (1.37) as at the balance sheet date.

» Debt/equity ratio was 58% as at the balance sheet date (85%).

» Cash flows from operating activities were SEK -3.5 million (-14.2) during the quarter. » As at the balance sheet date, the Group's cash and cash equivalents totaled SEK 23.6

million (32.1).

Significant events in the period

• July 15, 2020 | Cell Impact secures an order for production tools for serial production.
• July 31, 2020 | Cell Impact secures an additional order for production tools for serial production.
• August 4, 2020 | Positive final result of high-volume testing.
• September 2, 2020 | Beijing Nowogen Technology places an order for the production of flow plates.

For more information, please contact:

Stefan Axellie, CFO, [phone] or [e-mail].

About Cell Impact

Cell Impact AB (publ) is a global supplier of advanced flow plates to fuel cell manufacturers. The company has developed and patented a unique method for adiabatic high-velocity forming, which makes it possible to produce flow plates with more advanced designs, which in turn creates more cost and energy efficient fuel cells compared to conventional molding methods.

Cell Impact is listed on the Nasdaq First North Growth Market and FNCA Sweden AB is the company's Certified Adviser (CA). Contact information: [phone] or [e-mail].

This information is inside information that Cell Impact AB is obliged to make public pursuant to the

EU Market Abuse Regulation.